Hepatitis B Hepatitis B] Significant can occur at different stages of development and have different treatment methods and measures :

1] Significant performance hepatitis B virus carriers, liver function remained normal. Most stable at this stage, the prognosis is good, there is generally no need treatment, medication difficult to be effective at this time. more surely stand up and the combination of work and leisure combined and is not in favor of drug treatment and excessive insisting San negative. various antiviral drugs may not accomplish much. Strictly speaking, the carriers have not been patient, which is why drug therapy may not consider. The latest research indicates that the antiviral nuclear Gan adefovir or lamivudine. can be used in the treatment of HIV carriers (16 years old) and close observation for three months, If the target of hepatitis B virus replication (HBeAg HNV-DNB) conversion, sustainable medication 1-2, If three months invalid and may result in termination of medication.

2, patients with chronic persistent hepatitis B] Significant performance, and slightly abnormal liver function. B suggested that chronic mild liver damage. Anti-virus treatment to law, with the main treatment for lamivudine, supplement and medicine for 20 hours. Media treatment of long-term objective is normal liver function, hepatitis B virus replication indicators chemotherapy treatment for 1-2 years

3, chronic active hepatitis B] Significant performance, and the illness was serious, serum bilirubin, transaminase elevation Obviously, prothrombin activity decreased significantly. At this point the treatment of liver necrosis and laws to prevent anti-virus protective simultaneously, 20 hours with anti-viral drugs. Liver function tended goal is a balanced treatment, hepatitis B virus replication indicators gradually conversion. Lever balance, it can reduce or stop drug, anti-virus persist.

4] Significant performance cirrhotic patients. patients with decompensated liver cirrhosis or quiescent (B indicated cirrhosis, normal liver function checks). Treatment with anti-viral and anti-fibrotic rule simultaneously with the combination of interferon or Ruangan Lamy. The treatment goal is to target viral replication in patients and reduce the degree of hepatic fibrosis. Decompensated cirrhosis patients or period of performance] Significant activities, the main rule is not anti-virus treatment. but to control and prevent complications (ascites and pleural effusion, bleeding, infection, etc.) and restore liver function. When conditions will be considered anti-balance issues.

5, liver cancer patients] Significant performance, the most important principle for intervention and surgical treatment. balance condition will be considered anti-virus treatment.

This article was posted on 2007-02-27